These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15521210)

  • 1. [Ezetimib--a new possibility for combined therapy in hypercholesterolemia].
    Kvapil M
    Vnitr Lek; 2004 Aug; 50(8):643-4. PubMed ID: 15521210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid control in the double pack. Combined drugs to achieve the goal].
    MMW Fortschr Med; 2002 Jun; 144(23):53. PubMed ID: 12119910
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lowering cholesterol becomes easier. Combining instead of increasing dosage].
    MMW Fortschr Med; 2003 Jan; 145(3-4):59. PubMed ID: 12619241
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ezetimib. A new cholesterol absorption inhibitor].
    Heinzl S
    Med Monatsschr Pharm; 2002 Jul; 25(7):229-32. PubMed ID: 12148235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 9. [New therapeutic alternative to aggressive statin treatment].
    Haghfelt T
    Ugeskr Laeger; 2005 Jan; 167(2):186-7. PubMed ID: 15697135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
    Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C
    Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source].
    MMW Fortschr Med; 2005 Jun; 147(23):48-9. PubMed ID: 15981908
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent news reports suggest that the cholesterol medicine Zetia doesn't work. Should I stop taking my prescription?
    Johns Hopkins Med Lett Health After 50; 2008 Apr; 20(2):8. PubMed ID: 18705145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 16. Author's response.
    Gouni-Berthold I; Mikhailidis DP; Rizzo M
    Expert Opin Pharmacother; 2013 Dec; 14(18):2612-3. PubMed ID: 24371844
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on: Clinical benefits of ezetimibe: absence of proof is just that.
    Doggrell SA
    Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
    Spence JD
    Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
    Gouni-Berthold I; Mikhailidis DP; Rizzo M
    Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination of Zocor with Ezetrol].
    Thibaut P; Sternon J
    Rev Med Brux; 2006; 27(6):S526. PubMed ID: 17256422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.